Determinants of peritoneal solute transport rates in newly started nondiabetic peritoneal dialysis patients

Peritoneal Dialysis International

Volumn 24, Issue 6, 2004, Pages 554-561

  van Esch, Sadie ^a   Zweers, Machteld M ^a   Jansen, Maarten A M ^a   de Waart, Dirk R ^a   van Manen, Jeannette G ^b   Krediet, Raymond T ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Acute phase proteins; Appearance rates of hyaluronan; CA125; Comorbidity; IL 6; Small solute transport; VEGF

Indexed keywords

CA 125 ANTIGEN; CREATININE; HYALURONIC ACID; INTERLEUKIN 6; VASCULOTROPIN;

ADULT; AGED; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CELL MEMBRANE PERMEABILITY; CLINICAL ARTICLE; COMORBIDITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIABETES MELLITUS; DIALYSATE; DISEASE MARKER; FEMALE; HUMAN; KIDNEY DISEASE; LINEAR REGRESSION ANALYSIS; MALE; MESOTHELIUM CELL; PERITONEAL DIALYSIS; PERITONITIS; PREVALENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCORING SYSTEM; SOLUTE; STATISTICAL SIGNIFICANCE; UNIVERSITY HOSPITAL;

EID: 9444293355     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686080402400615     Document Type: Article

References (33)

1. Wang T, Heimbürger O, Waniewski J, Bergström J, Lindholm B. Increased peritoneal permeability is associated with decreased fluid and small-solute removal and higher mortality in CAPD patients. Nephrol Dial Transplant 1998; 13:1242-9.
2. Churchill DN, Thorpe KE, Nolph KD, Keshaviah PR, Oreopoulos DG, Page D, for the CANUSA Peritoneal Dialysis Study Group. Increased peritoneal membrane transport is associated with decreased patient and technique survival for continuous peritoneal dialysis patients. J Am Soc Nephrol 1998; 9:1285-92.
3. Jager KJ, Merkus MP, Dekker FW, Boeschoten EW, Tijssen JGP, Stevens P, et al., for the NECOSAD study group. Mortality and technique failure in patients starting chronic peritoneal dialysis: results of the Netherlands Cooperative Study on the Adequacy of Dialysis. Kidney Int 1999; 55:1476-85.
4. Krediet RT, Zemel D, Imholz ALT, Struijk DG. Impact of surface area and permeability on solute clearances. Perit Dial Int 1994; 14(Suppl 3):S70-7.
5. Chung SH, Chu WS, Lee HA, Kim YH, Lee IS, Lindholm B, et al. Peritoneal transport characteristics, comorbid diseases and survival in CAPD patients. Perit Dial Int 2000; 20:541-7.
6. Davies SJ, Phillips L, Naish PF, Russell GI. Quantifying co-morbidity in PD patients [Abstract]. J Am Soc Nephrol 2000; 11:205A.
7. Blake PG, Flowerdew G, Blake RM, Oreopoulos DG. Serum albumin in patients on continuous ambulatory peritoneal dialysis - predictors and correlation with outcome. J Am Soc Nephrol 1993; 3:1501-7.
8. Struijk DG, Krediet RT, Koomen GCM, Boeschoten EW, Arisz L. The effect of serum albumin at the start of continuous ambulatory peritoneal dialysis treatment on patient survival. Perit Dial Int 1994; 14:121-6.
9. Stenvinkel P, Heimbürger O, Paultre F, Diczfalusy U, Wang T, Berglund L, et al. Strong associations between malnutrition, inflammation and atherosclerosis in chronic renal failure. Kidney Int 1999; 55:1899-911.
10. Stenvinkel P, Heimbürger O, Lindholm B, Kaysen GA, Bergström J. Are there two types of malnutrition in chronic renal failure? Evidence for relationships between malnutrition, inflammation and atherosclerosis (MIA syndrome). Nephrol Dial Transplant 2000; 15: 953-60.
11. Hutten H, Zweers MM, de Waart DR, Jansen MAM, Krediet RT. Cancer antigen 125, peritoneal transport parameters and duration of peritoneal dialysis (PD) [Abstract]. Perit Dial Int 2001; 21(Suppl 2):S133.
12. Koomen GCM, Betjes MGH, Zemel D, Krediet RT, Hoek FJ. Dialysate cancer antigen (CA) 125 is a reflection of the peritoneal cell mass in CAPD patients. Perit Dial Int 1994; 14:132-6.
13. Visser CE, Brouwer-Steenbergen JJE, Betjes MGH, Koomen GCM, Beelen RJH, Krediet RT. Cancer antigen 125: a mesothelial bulk marker for mesothelial mass in stable peritoneal dialysis patients. Nephrol Dial Transplant 1995; 1:64-9.
14. Topley N, Williams JD. Role of the peritoneal membrane in the control of inflammation in the peritoneal cavity. Kidney Int Suppl 1994; 48:71-8.
15. Selgas R, del Peso G, Bajo MA, Castro MA, Molina S, Cirugeda A, et al. Spontaneous VEGF production by cultured peritoneal mesothelial cells from patients on peritoneal dialysis. Perit Dial Int 2000; 20:798-801.
16. Devuyst O. Molecular mechanisms of peritoneal permeability - research in growth factors. Perit Dial Int 2001; 21(Suppl 3):S19-23.
17. Combet S, Miyata T, Moulin P, Pouthier D, Goffin E, Devuyst O. Vascular proliferation and enhanced expression of endothelial nitric oxide synthase in human peritoneum exposed to long-term peritoneal dialysis. J Am Soc Nephrol 2000; 11:717-28.
18. Davies SJ, Russell L, Bryan J, Phillips L, Russell GI. Co-morbidity, urea kinetics, and appetite in continuous ambulatory peritoneal dialysis patients: their interrelationship and prediction of survival. Am J Kidney Dis 1995; 26:353-61.
19. Pannekeet MM, Imholz ALT, Struijk DG. The standard peritoneal permeability analysis: a tool for the assessment of peritoneal permeability characteristics in CAPD patients. Kidney Int 1995; 48:866-75.
20. Smit W, van Dijk P, Schouten N, Langedijk M, van den Berg N, Struijk DG, et al. Peritoneal function and assessment of reference values using a 3.86% glucose solution. Perit Dial Int 2003; 23:440-9.
21. Waniewski J, Werynski A, Heimbürger O, Lindholm B. Simple models for description of small-solute transport in peritoneal dialysis. Blood Purif 1991; 9:129-41.
22. Waniewski J, Heimbürger O, Werynski A, Lindholm B. Aqueous solute concentrations and evaluations of mass transport coefficients in peritoneal dialysis. Nephrol Dial Transplant 1992; 11:11-14.
23. Zemel D, Imholz ALT, de Waart DR, Dinkla C, Struijk DG, Krediet RT. Appearance of tumor necrosis factor-α and soluble TNF-receptors I and II in peritoneal effluent of CAPD. Kidney Int 1994; 46:1422-30.
24. Heimbürger O, Wang T, Chung SH, Ohlsson S, Lindholm B, Stenvinkel P. Increased peritoneal transport rate from an early peritoneal equilibration test (PET) is related to inflammation, cardiovascular disease and mortality [Abstract]. J Am Soc Nephrol 1999; 10:315A.
25. Pecoits-Filho R, Araújo MR, Lindholm B, Stenvinkel P, Abensur H, Romão JE Jr, et al. Plasma and dialysate IL-6 and VEGF concentrations are associated with high peritoneal solute transport rate. Nephrol Dial Transplant 2002; 17:1480-6.
26. Struijk DG, Krediet RT, Koomen GCM, Boeschoten EW, Hoek FJ, Arisz L. A prospective study of peritoneal transport in CAPD patients. Kidney Int 1994; 45: 1739-44.
27. Aiello LP, Avery RL, Arrigg PF, Keyt BA, Jampel HD, Shah ST, et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 1994; 331: 1480-7.
28. Dvorak HF, Brown LF, Detmar M, Dvorak AM. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 1995; 146:1029-39.
29. Tanaka Y, Katoh S, Hori S, Miura M, Yamashita H. Vascular endothelial growth factor in diabetic retinopathy. Lancet 1997; 349:1520.
30. Zweers MM, de Waart DR, Smit W, Struijk DG, Krediet RT. Growth factors VEGF and TGF-β in peritoneal dialysis. J Lab Clin Med 1999; 134:124-32.
31. Krediet RT. Advances in peritoneal dialysis: towards improved efficacy and safety. Blood Purif 1998; 16:1-14.
32. Krediet RT. Dialysate cancer antigen 125 concentration as marker of peritoneal membrane status in patients treated with chronic peritoneal dialysis. Perit Dial Int 2001; 21:560-7.
33. Lai KN, Lai KB, Szeto CC, Ho KKL, Poon P, Lam CWK, et al. Dialysate cell population and cancer antigen 125 in stable continuous ambulatory peritoneal dialysis patients: their relationship with transport parameters. Am J Kidney Dis 1997; 29:699-705.